Related Experiment Video
Updated: May 7, 2026

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
Published on: April 15, 2020
New insights into lipid raft function regulating myocardial vascularization competency in human idiopathic dilated
Santiago Roura1, Carolina Gálvez-Montón, Josep M Pujal
1ICREC Research Program, Germans Trias i Pujol Health Science Research Institute, Badalona, Spain.
Insights
In idiopathic dilated cardiomyopathy (IDCM), the heart
Area of Science:
- Cardiovascular Biology
- Cellular and Molecular Medicine
Background:
- Idiopathic dilated cardiomyopathy (IDCM) is characterized by impaired myocardial vascularization.
- The underlying causes, including cellular responses and vascularization demand, remain unclear.
Purpose of the Study:
- To investigate the role of circulating angiogenic-supportive cells and myocardial vascularization in IDCM.
- To explore the mechanisms behind vascular derangements in IDCM.
Main Methods:
- Comparison of left ventricle (LV) tissue from IDCM hearts and control hearts.
- Isolation and analysis of peripheral pro-angiogenic cells from IDCM patients and healthy volunteers.
- Assessment of stromal cell-derived factor (SDF)-1α, integrin-linked kinase (ILK), and lipid raft localization.
Main Results:
- Increased ILK levels and activity in IDCM hearts, with SDF-1α co-localizing in lipid rafts.
- Pro-angiogenic cells from IDCM patients showed reduced SDF-1-mediated migration and decreased ILK/ERK signaling.
- No difference in myocardial vascularization competency or CXCR-4 surface levels was observed.
Conclusions:
- Myocardial vascularization capacity is not impaired in IDCM.
- Dysfunctional SDF-1-mediated cell migration, linked to ILK/ERK signaling, may hinder endothelial recovery in IDCM.
- Findings offer insights into lipid raft function and potential therapeutic targets for IDCM.
Objective:
Idiopathic dilated cardiomyopathy (IDCM) affects myocardial vascularization. Whether a lack of demand for increased myocardial vascularization and/or an impaired response of circulating angiogenic-supportive cells are responsible for the vascular derangements found in IDCM is unknown.
Methods And Results:
Left ventricle (LV) samples obtained at transplant from IDCM hearts were compared to control hearts from non-cardiac decedents. Peripheral colony-forming myeloid cells were extracted from age- and sex-matched IDCM patients and healthy volunteers. At the tissue level, no differences were detected in stromal cell-derived factor (SDF)-1α expression, but integrin-linked kinase (ILK) levels and activity were increased in IDCM. A marked co-localization of SDF-1α and the specific marker of cholesterol-enriched lipid rafts Flotillin (Flot)-1 was found in IDCM. SDF-1α was also highly distributed into IDCM lipid rafts. Non-adherent pro-angiogenic cells from both groups, which were found increased in patients but showed similar surface levels of CXCR-4, equally supported Matrigel-mediated cell network formation. However, SDF-1-mediated migration was reduced in IDCM-derived cells, which also exhibited decreased ILK activity and downstream ERK activation.
Conclusions:
Taken together, our results point out that myocardial competency to increase vascularization is not altered in IDCM, but dysfunctional SDF-1-mediated migration by peripheral pro-angiogenic cells through ILK and downstream ERK signaling may compromise endothelial recovery in patients. We provide new insights into lipid raft function in human IDCM and envision more effective treatments.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy